These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 13651338)

  • 1. Evaluation of plasma erythropoietic-stimulating factors in anemic uremic patients.
    GALLAGHER NI; McCARTHY JM; HART KT; LANGE RD
    Blood; 1959 Jun; 14(6):662-7. PubMed ID: 13651338
    [No Abstract]   [Full Text] [Related]  

  • 2. Observations on erythropoietic-stimulating factor (ESF) in the plasma of uremic and nonuremic anemic patients.
    GALLAGHER NI; McCARTHY JM; LANGE RD
    Ann Intern Med; 1960 Jun; 52():1201-12. PubMed ID: 13826088
    [No Abstract]   [Full Text] [Related]  

  • 3. The relationship between hematocrit and erythrocyte magnesium concentration in patients on regular hemodialysis.
    Gonella M; Betti G; Buzzigoli G; Bartolini V
    Nephron; 1979; 24(3):134-7. PubMed ID: 492423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietic stimulating effects of plasma extracts from anemic human subjects.
    GORDON AS; LUHBY AL; MEDICI PT; PANSKY B; PILIERO SJ
    Proc Soc Exp Biol Med; 1956 Nov; 93(2):302-5. PubMed ID: 13379493
    [No Abstract]   [Full Text] [Related]  

  • 5. Involvement of phosphatidylserine exposure in the recognition and phagocytosis of uremic erythrocytes.
    Bonomini M; Sirolli V; Reale M; Arduini A
    Am J Kidney Dis; 2001 Apr; 37(4):807-14. PubMed ID: 11273881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of middle molecules on the anemia of uremic patients.
    Leber HW; Spiegelhalter R; Ulm A; Goubeaud G; Rawer P
    Artif Organs; 1978 Nov; 2(4):378-81. PubMed ID: 743010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of bone marrow erythroid colony-forming cells (CFU-E) by serum from chronic anemic uremic rabbits (39874).
    Ohno Y; Fisher JW
    Proc Soc Exp Biol Med; 1977 Oct; 156(1):56-9. PubMed ID: 302949
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacological use of L-carnitine in uremic anemia: has its full potential been exploited?
    Bonomini M; Zammit V; Pusey CD; De Vecchi A; Arduini A
    Pharmacol Res; 2011 Mar; 63(3):157-64. PubMed ID: 21138768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbonic anhydrase isoenzyme B in erythrocytes of anemic and non-anemic uremic subjects.
    Anker N; Mondrup M
    Clin Chim Acta; 1977 Sep; 79(2):341-7. PubMed ID: 408056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superoxide dismutase activity and reduced glutathione content in erythrocytes of uremic patients on chronic dialysis.
    Vanella A; Geremia E; Pinturo R; Tiriolo P; Liuzzo G; Tiriolo C; Custorella A; Condorelli G; Giglio A
    Acta Haematol; 1983; 70(5):312-5. PubMed ID: 6414225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitor of insulin binding to erythrocytes in plasma of uremic patients.
    Milutinović S; Breyer D; Janković N; Molnar V; Stefović A; Rocić B
    Nephron; 1983; 34(2):99-103. PubMed ID: 6346120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole blood superoxide anion generation and efficiency of some erythrocyte antioxidant systems during recombinant human erythropoietin therapy of uremic anemia.
    Luciak M; Pawlicki L; Kedziora J; Trznadel K; Błaszczyk J; Buczyński A
    Free Radic Biol Med; 1991; 10(6):397-401. PubMed ID: 1654288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of erythrocytes phosphatidylserine exposure in anemia in peritoneal dialysis patients.
    Bi SH; Cheng LT; Wang T
    Ren Fail; 2006; 28(7):573-6. PubMed ID: 17050240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin activity in acutely uremic mice.
    Mirand EA; Gordon AD; Murphy GP
    J Med; 1975; 6(3-4):261-70. PubMed ID: 1059720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of erythropoietic stimulating factor in anemic patients with or without renal disease.
    NAETS JP; HEUSE AF
    J Lab Clin Med; 1962 Sep; 60():365-74. PubMed ID: 14477839
    [No Abstract]   [Full Text] [Related]  

  • 16. The red blood cell as a model for the study of uremic toxins.
    Smith EK; Welt LG
    Arch Intern Med; 1970 Nov; 126(5):827-30. PubMed ID: 4248903
    [No Abstract]   [Full Text] [Related]  

  • 17. Polyamine induced suppression of erythropoiesis in uremia.
    Radtke W; Scheuermann E; Desser H
    Haematologia (Budap); 1984; 17(2):151-60. PubMed ID: 6534823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inverse relationship between erythroid colony-stimulating and inhibiting activities in plasma from non-uremic anemic patients.
    Sakata S; Enoki Y; Morimoto T; Matsumura K
    Eur J Haematol; 1992 May; 48(5):272-3. PubMed ID: 1644160
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathogenetic aspects of anemia in long-term hemodialyzed patients.
    Buscarini L
    Acta Haematol; 1976; 55(5-2):265-71. PubMed ID: 821289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anemia of chronic renal failure in sheep. Response to erythropoietin-rich plasma in vivo.
    Eschbach JW; Mladenovic J; Garcia JF; Wahl PW; Adamson JW
    J Clin Invest; 1984 Aug; 74(2):434-41. PubMed ID: 6746902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.